Effectiveness and safety of rivaroxaban and warfarin for prevention of major adverse cardiovascular or limb events in patients with non-valvular atrial fibrillation and type 2 diabetes.

Baker, William L; Beyer-Westendorf, Jan; Bunz, Thomas J; Eriksson, Daniel; Meinecke, Anna-Katharina; Sood, Nitesh A; Coleman, Craig I

Baker, William L; Beyer-Westendorf, Jan; Bunz, Thomas J; Eriksson, Daniel; Meinecke, Anna-Katharina; Sood, Nitesh A; Coleman, Craig I.

Affiliation

Baker WL; Department of Pharmacy Practice, University of Connecticut School of Pharmacy, Storrs, Connecticut.
Beyer-Westendorf J; Evidence-Based Practice Center, Hartford Hospital, Hartford, Connecticut.
Bunz TJ; Department of Medicine, Hematology Division, Dresden University, Dresden, Germany.
Eriksson D; Department of Pharmacoepidemiology, New England Health Analytics, Granby, Connecticut.
Meinecke AK; Real-World Evidence Generation, Bayer AG, Berlin, Germany.
Sood NA; Real-World Evidence Generation, Bayer AG, Berlin, Germany.
Coleman CI; Department of Cardiac Electrophysiology, Southcoast Health System, Fall River, Massachusetts.

Diabetes Obes Metab ; 21(9): 2107-2114, 2019 09.

Article in En | MEDLINE | ID: mdl-31099460

Subject(s)

Anticoagulants/therapeutic use; Atrial Fibrillation/drug therapy; Cardiovascular Diseases/prevention & control; Diabetes Mellitus, Type 2/complications; Rivaroxaban/therapeutic use; Warfarin/therapeutic use; Adolescent; Adult; Aged; Aged, 80 and over; Atrial Fibrillation/complications; Cardiovascular Diseases/etiology; Female; Humans; Male; Middle Aged; Peripheral Arterial Disease/etiology; Peripheral Arterial Disease/prevention & control; Propensity Score; Retrospective Studies; Treatment Outcome; Young Adult

Key words

anticoagulation; atrial fibrillation; bleeding; cardiovascular outcomes; lower limb complications; rivaroxaban; warfarin

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Atrial Fibrillation / Warfarin / Cardiovascular Diseases / Diabetes Mellitus, Type 2 / Rivaroxaban / Anticoagulants Type of study: Etiology_studies / Evaluation_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Year: 2019 Type: Article

Fulltext

XML

PubMed Links

Search on Google